Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 38
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

GRANULES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 40
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

MYLAN

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 59
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 46
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SUNSHINE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

LUPIN LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text
  • Previous
  • 246
  • 247
  • 248
  • 249
  • 250
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122402)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin